Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker
- PMID: 7745743
- PMCID: PMC189114
- DOI: 10.1128/JVI.69.6.3900-3903.1995
Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker
Abstract
Certain classes of human T-cell lymphomas have been shown to be persistently infected with Epstein-Barr virus (EBV). To achieve an experimental system of persistent EBV infection in T cells, we used EBV recombinants with a positive selection marker. Infection of the human T-cell line MT-2 with EBV recombinants that had a hygromycin resistance gene and subsequent selection with this drug permitted isolation and long-term maintenance of EBV-infected MT-2 clones. For each clone, essentially 100% of cells were positive for EBV nuclear antigen. These MT-2 clones harbor monoclonal episomes of EBV DNA and stably express two EBV latent proteins, EBV nuclear antigen 1 and latent membrane protein 1. The growth of these EBV-infected MT-2 clones was slower than that of uninfected clones, suggesting that EBV affects regulation of T-cell proliferation. EBV recombinants with a positive selection marker will be a useful tool in establishing experimental systems of persistent EBV infection in certain non-B-cell lineages.
Similar articles
-
[Isolation and characterization of Epstein-Barr virus-infected clones of a human T-lymphoblastoid cell line].Nihon Rinsho. 1997 Feb;55(2):416-23. Nihon Rinsho. 1997. PMID: 9046834 Review. Japanese.
-
Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.J Virol. 1991 Apr;65(4):1701-9. doi: 10.1128/JVI.65.4.1701-1709.1991. J Virol. 1991. PMID: 1848303 Free PMC article.
-
Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.J Virol. 1992 Aug;66(8):4972-81. doi: 10.1128/JVI.66.8.4972-4981.1992. J Virol. 1992. PMID: 1321281 Free PMC article.
-
Epstein-Barr-virus-infected human T-cell line with a unique pattern of viral-gene expression.Int J Cancer. 1998 May 18;76(4):587-94. doi: 10.1002/(sici)1097-0215(19980518)76:4<587::aid-ijc23>3.0.co;2-3. Int J Cancer. 1998. PMID: 9590138
-
[Analysis of EBV infection in various cell types with recombinant EBV].Nihon Rinsho. 1997 Feb;55(2):311-5. Nihon Rinsho. 1997. PMID: 9046816 Review. Japanese.
Cited by
-
Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma.Cancer Sci. 2014 Jun;105(6):713-22. doi: 10.1111/cas.12418. Epub 2014 May 13. Cancer Sci. 2014. PMID: 24712440 Free PMC article.
-
Epstein-barr virus (EBV) nuclear protein 2-induced disruption of EBV latency in the Burkitt's lymphoma cell line Akata: analysis by tetracycline-regulated expression.J Virol. 1999 Jun;73(6):5214-9. doi: 10.1128/JVI.73.6.5214-5219.1999. J Virol. 1999. PMID: 10233991 Free PMC article.
-
The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas.Front Microbiol. 2015 Apr 9;6:280. doi: 10.3389/fmicb.2015.00280. eCollection 2015. Front Microbiol. 2015. PMID: 25914683 Free PMC article.
-
How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection.Viruses. 2022 Oct 27;14(11):2372. doi: 10.3390/v14112372. Viruses. 2022. PMID: 36366470 Free PMC article. Review.
-
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.J Virol. 2007 Sep;81(18):10092-100. doi: 10.1128/JVI.00358-07. Epub 2007 Jul 11. J Virol. 2007. PMID: 17626071 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials